David G. McLeod
George Washington University · 458 works · 17,565 citations · h-index 70
Top works
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic Carcinoma
- Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
- Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer
- Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men
- Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome
- Pathologic Variables and Recurrence Rates As Related to Obesity and Race in Men With Prostate Cancer Undergoing Radical Prostatectomy
- NEOADJUVANT ANDROGEN ABLATION BEFORE RADICAL PROSTATECTOMY IN cT2bNxMo PROSTATE CANCER: 5-YEAR RESULTS
- Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy
- Black Race is an Adverse Prognostic Factor for Prostate Cancer Recurrence Following Radical Prostatectomy in an Equal Access Health Care Setting
- Treatment of newly diagnosed metastatic prostate cancer patients with chemotherapy agents in combination with hormones versus hormones alone
- Black race is an adverse prognostic factor for prostate cancer recurrence following radical prostatectomy in an equal access health care setting.
- MULTICENTER PATIENT SELF-REPORTING QUESTIONNAIRE ON IMPOTENCE, INCONTINENCE AND STRICTURE AFTER RADICAL PROSTATECTOMY
- PCGEM1 , a prostate-specific gene, is overexpressed in prostate cancer
- Bicalutamide 150 mg plus standard care vs standard care alone for early prostate cancer
- Predictors of Prostate Cancer–Specific Mortality After Radical Prostatectomy or Radiation Therapy
- Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study
- Taxol in advanced, hormone-refractory carcinoma of the prostate. A phase II trial of the eastern cooperative oncology group
- Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy
- Early Versus Delayed Hormonal Therapy for Prostate Specific Antigen Only Recurrence of Prostate Cancer After Radical Prostatectomy
- BIOSTATISTICAL MODELING USING TRADITIONAL PREOPERATIVE AND PATHOLOGICAL PROGNOSTIC VARIABLES IN THE SELECTION OF MEN AT HIGH RISK FOR DISEASE RECURRENCE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER